Efficacy and safety of elranatamab in patients with relapsed/refractory multiple myeloma naïve to B-cell maturation antigen (BCMA)-directed therapies: Results from Cohort A of the MagnetisMM-3 study Meeting Abstract
| Authors: | Bahlis, N. J.; Tomasson, M. H.; Mohty, M.; Niesvizky, R.; Nooka, A. K.; Manier, S.; Maisel, C.; Jethava, Y.; Martinez-Lopez, J.; Prince, H. M.; Arnulf, B.; Otero, P. R.; Koehne, G.; Touzeau, C.; Raje, N.; Iida, S.; Raab, M. S.; Leip, E.; Sullivan, S.; Conte, U.; Viqueira, A.; Lesokhin, A. M. |
| Abstract Title: | Efficacy and safety of elranatamab in patients with relapsed/refractory multiple myeloma naïve to B-cell maturation antigen (BCMA)-directed therapies: Results from Cohort A of the MagnetisMM-3 study |
| Meeting Title: | 64th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 140 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2022 Dec 10-13 |
| Meeting Location: | New Orleans, LA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2022-11-15 |
| Start Page: | 391 |
| End Page: | 393 |
| Language: | English |
| ACCESSION: | WOS:000893223200160 |
| DOI: | 10.1182/blood-2022-162440 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
